State Street’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.29M | Buy |
1,239,663
+872,353
| +237% | +$4.42M | ﹤0.01% | 2837 |
|
2025
Q1 | $1.11M | Buy |
367,310
+66,800
| +22% | +$202K | ﹤0.01% | 3405 |
|
2024
Q4 | $1.09M | Buy |
300,510
+132,202
| +79% | +$479K | ﹤0.01% | 3474 |
|
2024
Q3 | $296K | Hold |
168,308
| – | – | ﹤0.01% | 3721 |
|
2024
Q2 | $263K | Buy |
168,308
+1,500
| +0.9% | +$2.34K | ﹤0.01% | 3741 |
|
2024
Q1 | $325K | Hold |
166,808
| – | – | ﹤0.01% | 3758 |
|
2023
Q4 | $235K | Hold |
166,808
| – | – | ﹤0.01% | 3864 |
|
2023
Q3 | $264K | Hold |
166,808
| – | – | ﹤0.01% | 3855 |
|
2023
Q2 | $360K | Buy |
166,808
+83,900
| +101% | +$181K | ﹤0.01% | 3793 |
|
2023
Q1 | $174K | Hold |
82,908
| – | – | ﹤0.01% | 4124 |
|
2022
Q4 | $182K | Hold |
82,908
| – | – | ﹤0.01% | 4144 |
|
2022
Q3 | $249K | Hold |
82,908
| – | – | ﹤0.01% | 4040 |
|
2022
Q2 | $235K | Hold |
82,908
| – | – | ﹤0.01% | 4126 |
|
2022
Q1 | $444K | Buy |
82,908
+26,909
| +48% | +$144K | ﹤0.01% | 4101 |
|
2021
Q4 | $418K | Hold |
55,999
| – | – | ﹤0.01% | 4087 |
|
2021
Q3 | $508K | Buy |
55,999
+800
| +1% | +$7.26K | ﹤0.01% | 3973 |
|
2021
Q2 | $269K | Buy |
+55,199
| New | +$269K | ﹤0.01% | 4103 |
|
2016
Q2 | – | Sell |
-4,878
| Closed | -$270K | – | 3769 |
|
2016
Q1 | $270K | Buy |
4,878
+1,664
| +52% | +$92.1K | ﹤0.01% | 3457 |
|
2015
Q4 | $444K | Sell |
3,214
-7
| -0.2% | -$967 | ﹤0.01% | 3355 |
|
2015
Q3 | $461K | Buy |
3,221
+558
| +21% | +$79.9K | ﹤0.01% | 3351 |
|
2015
Q2 | $691K | Buy |
+2,663
| New | +$691K | ﹤0.01% | 3313 |
|